770
H.-K. Zhang et al. / Tetrahedron: Asymmetry 16 (2005) 761–771
NMR (270 MHz, CDCl3): d 1.14 (d, J = 7.0 Hz, 3H),
1.39 (dd, J = 1.6, 8.9 Hz, 1H), 1.54 (br s, 1H), 1.99 (m,
1H), 2.50 (br s, 1H), 2.92 (t, J = 4.1 Hz, 1H), 3.19 (br
s, 1H), 4.00 (dd, J = 4.3, 13.8 Hz, 1H), 4.55 (d,
J = 13.8 Hz, 1H), 5.29 (d, J = 9.2 Hz, 1H), 5.53 (dd,
J = 3.5, 9.2 Hz, 1H), 5.84 (dd, J = 2.7, 5.7 Hz, 1H),
6.34 (dd, J = 3.2, 5.7 Hz, 1H), 7.50 (m, 3H), 7.76 (m,
2H); 13C NMR (67.8 MHz, CDCl3): d 20.4, 38.5, 47.1,
47.4, 48.5, 49.6, 53.2, 71.6, 79.5, 126.8, 127.2, 129.1,
131.2, 139.1, 151.7, 172.4; IR (KBr): 2927, 1718, 1651,
129.1, 131.0, 135.2, 135.9, 139.1, 172.9; IR (KBr):
;
2923, 2876, 1705, 1457, 1394, 1016, 918, 706 cmꢀ1
HRMS (ESI) m/z C20H29N2O4S (M+H)+. Calcd:
465.1848. Found: 465.1852.
3.6.5. (3R,3aR,6aR)-5-N-{(1S*,2R*,3S*,4R*)-3-Methyl-
bicyclo[2,2,1]hept-5-en-2-formyl}-3-phenyl-4,5-thiazolidine-
4,4-dioxide[3,4-d]isoxazolidine
17e. Yield
9%;
18
D
½aꢁ ¼ ꢀ22 (c 0.38, CHCl3); 1H NMR (270 MHz,
CDCl3): d 1.14 (d, J = 7.0 Hz, 3H), 1.51 (d, J = 8.6 Hz,
1H), 1.62 (d, J = 8.8 Hz, 1H), 2.01 (m, 1H), 2.62 (br s,
1H), 3.00 (t, J = 3.5 Hz, 1H), 3.37 (br s, 1H), 3.63 (dd,
J = 4.2, 13.6 Hz, 1H), 3.76 (d, J = 13.6 Hz, 1H), 4.06
(d, J = 13.6 Hz, 1H), 4.10 (d, J = 6.8 Hz, 1H), 4.15 (d,
J = 13.6 Hz, 1H), 4.35 (d, J = 6.8 Hz, 1H), 4.94 (dd,
J = 4.3, 7.2 Hz, 1H), 5.88 (dd, J = 2.7, 5.7 Hz, 1H),
6.38 (dd, J = 2.7, 5.7 Hz, 1H), 7.29 (m, 5H), 7.43 (m,
3H), 7.53 (m, 2H); HRMS (ESI) m/z C20H29N2O4S
(M+H)+. Calcd: 465.1848. Found: 465.1856.
1446, 1353, 1336, 1235, 1209, 1132, 917, 773 cmꢀ1
;
HRMS (ESI) m/z C19H20N2O4NaS (M+Na)+. Calcd:
395.1041. Found: 395.1043.
3.6.2. (3aR,6aR)-5-N-{(1S*,2R*,3S*,4R*)-3-Methyl-
bicyclo[2,2,1]hept-5-en-2-formyl}-3-phenyl-4,5-thiazolidine-
4,4-dioxide-[3,4-d]-2-isoxazoline
17a. Yield
7%;
18
D
½aꢁ ¼ ꢀ308 (c 0.42, CHCl3); 1H NMR (270 MHz,
CDCl3): d 1.08 (d, J = 7.0 Hz, 3H), 1.45 (dd, J = 1.6,
8.8 Hz, 1H), 1.57 (br m, 1H), 1.95 (m, 1H), 2.65 (br
m, 1H), 3.06 (t, J = 4.0 Hz, 1H), 3.28 (br m, 1H), 3.85
(dd, J = 4.3, 13.8 Hz, 1H), 4.63 (d, J = 14.0 Hz, 1H),
5.31 (d, J = 9.2 Hz, 1H), 5.51 (dd, J = 3.2, 9.2 Hz, 1H),
5.84 (dd, J = 2.7, 5.8 Hz, 1H), 6.32 (dd, J = 2.7,
5.8 Hz, 1H), 7.46 (m, 3H), 7.73 (m, 2H); 13C NMR
(100.6 MHz, CDCl3): d 20.0, 37.8, 46.8, 47.3, 47.8,
49.2, 52.3, 71.6, 80.0, 126.7, 127.2, 129.0, 131.1, 139.4,
151.8, 172.4; HRMS (ESI) m/z C19H20N2O4NaS
(M+Na)+. Calcd: 395.1041. Found: 395.1047.
3.6.6. (3R,3aR,6aR)-5-N-{(1R*,2S*,4S*)-Bicyclo[2,2,1]-
hept-5-en-2-formyl}-3-phenyl-4,5-thiazolidine-4,4-dioxide-
21
D
[3,4-d]isoxazolidine 16g. Yield 65%; ½aꢁ ¼ þ15:8 (c
1
0.60, CHCl3); H NMR (270 MHz, CDCl3): d 1.26 (br
s, 1H), 1.37–1.50 (m, 3H), 2.00–2.08 (m, 1H), 2.95 (br
m, 1H), 3.40 (br m, 1H), 3.51–3.59 (m, 1H), 3.71–3.79
(m, 1H), 3.99 (t, J = 14.3 Hz, 1H), 4.11–4.18 (m, 1H),
4.24–4.41 (m, 2H), 4.93 (dd, J = 4.1, 7.0 Hz, 1H), 5.93
(qq, J = 3.0, 7.0 Hz, 1H), 6.25 (dd, J = 3.0, 7.0 Hz,
1H), 7.27–7.54 (m, 10H); 13C NMR (67.8 MHz, CDCl3):
d 30.1, 30.8, 42.9, 43.9, 44.7, 47.0, 49.9, 59.1, 73.7, 74.8,
127.5, 128.0, 128.2, 128.7, 129.1, 129.2, 132.1, 135.2,
136.1, 137.7, 172.9; IR (KBr): 2971, 2876, 1701, 1456,
1348, 1331, 1247, 1190, 1027, 699 cmꢀ1; HRMS (ESI)
m/z C25H26N2NaO4S (M+Na)+. Calcd: 473.1511.
Found: 473.1515.
3.6.3. (3aS,6aS)-5-N-{(1S*,2R*,4R*)-Bicyclo[2,2,1]hept-
5-en-2-formyl}-3-phenyl-4,5-thiazolidine-4,4-dioxide-[3,4-
d]-2-isoxazoline 17c. Yield 62%; mp 218–220 ꢁC;
18
½aꢁ ¼ ꢀ239:2 (c 0.80, CHCl3); 1H NMR (400 MHz,
D
CDCl3): d 1.24–1.54 (m, 3H), 1.83–1.89 (m, 1H), 2.91
(br s, 1H), 3.39 (br s, 1H), 3.55 (m, 1H), 3.88 (dd,
J = 4.0, 14.0 Hz, 1H), 4.74 (d, J = 13.6 Hz, 1H), 5.30
(dd, J = 8.8, 17.2 Hz, 1H), 5.53 (m, 1H), 5.88 (dd,
J = 2.8, 5.6 Hz, 1H), 6.25 (dd, J = 2.8, 5.6 Hz, 1H),
7.50 (m, 3H), 7.76 (m, 2H); 13C NMR (67.8 MHz,
CDCl3): d 30.8, 42.8, 44.9, 47.0, 47.1, 49.9, 71.6, 79.8,
127.3, 129.1, 131.3, 132.1, 137.6, 138.1, 151.6, 171.8;
IR (KBr): 2977, 1711, 1565, 1447, 1350, 1241, 1178,
915, 772 cmꢀ1; HRMS (ESI) m/z C18H18N2O4NaS
(M+Na)+. Calcd: 381.0884. Found: 381.0910.
3.6.7. (3R,3aR,6aR)-5-N-{(1S*,2R*,4R*)-Bicyclo[2,2,1]-
hept-5-en-2-formyl}-3-phenyl-4,5-thiazolidine-4,4-dioxide-
18
D
[3,4-d]isoxazolidine 17g. Yield 18%; ½aꢁ ¼ ꢀ11 (c
1
0.35, CHCl3); H NMR (270 MHz, CDCl3): d 1.28 (m,
1H), 1.40–1.56 (m, 3H), 1.88–2.06 (m, 1H), 3.05 (m,
1H), 3.43 (m, 1H), 3.49–3.57 (m, 1H), 3.65–3.76 (m,
1H), 4.02 (t, J = 14.3 Hz, 1H), 4.12–4.17 (m, 1H),
4.26–4.38 (m, 2H), 4.95 (dd, J = 4.0, 7.2 Hz, 1H), 5.87
(dd, J = 3.0, 5.7 Hz, 1H), 6.18 (dd, J = 3.0, 5.7 Hz,
1H), 7.25–7.56 (m, 10H); 13C NMR (67.8 MHz, CDCl3):
3.6.4. (3R,3aR,6aR)-5-N-{(1R*,2S*,3R*,4S*)-3-Methyl-
bicyclo[2,2,1]hept-5-en-2-formyl}-3-phenyl-4,5-thiazolidine-
d
31.3, 32.0, 42.8, 43.9, 45.3, 47.1, 50.2, 59.1,
73.8, 74.0, 127.3, 127.8, 128.2, 128.7, 129.1, 129.2,
131.1, 135.4, 136.2, 137.9, 172.5; HRMS (ESI) m/z
C25H26N2NaO4S (M+Na)+. Calcd: 473.1511. Found:
473.1518.
4,4-dioxide[3,4-d]isoxazolidine
16e. Yield
81%;
18
D
½aꢁ ¼ þ42:4 (c 1.05, CHCl3); 1H NMR (270 MHz,
CDCl3): d 1.15 (d, J = 7.0 Hz, 3H), 1.50 (d, J = 8.6 Hz,
1H), 1.70 (d, J = 8.9 Hz, 1H), 2.03 (m, 1H), 2.55 (br
m, 1H), 3.01 (t, J = 3.5 Hz, 1H), 3.37 (s, 1H), 3.62 (dd,
J = 4.3, 13.5 Hz, 1H), 3.78 (d, J = 14.3 Hz, 1H), 4.03
(d, J = 14.3 Hz, 1H), 4.13 (d, J = 6.8 Hz, 1H), 4.20 (d,
J = 13.5 Hz, 1H), 4.35 (d, J = 6.8 Hz, 1H), 4.94 (dd,
J = 4.3, 7.0 Hz, 1H), 5.89 (dd, J = 2.7, 5.7 Hz, 1H),
6.39 (dd, J = 2.7, 5.7 Hz, 1H), 7.26 (m, 5H), 7.42 (m,
3H), 7.53 (d, J = 9.2 Hz, 2H); 13C NMR (67.8 MHz,
CDCl3): d 20.4, 38.1, 45.5, 47.1, 48.2, 49.5, 52.8, 59.0,
73.2, 73.7, 74.7, 127.4, 127.8, 128.1, 128.6, 129.0,
3.6.8. (3R,3aR,6aR)-5-N-{(1R*,2S*,3R*,4S*)-3-Methyl-
bicyclo[2,2,1]hept-5-en-2-formyl}-3-pyrenyl-4,5-thiazolidine-
4,4-dioxide[3,4-d]isoxazolidine
16h. Yield
80%;
21
D
½aꢁ ¼ þ83:3 (c 1.7, CHCl3); 1H NMR (400 MHz,
CDCl3): d 1.16 (d, J = 6.8 Hz, 3H), 1.55–1.60 (m, 2H),
1.75 (d, J = 8.4 Hz, 1H), 2.05 (m, 1H), 2.57 (s, 1H),
3.08 (t, J = 3.6 Hz, 1H), 3.51 (s, 1H), 3.74 (dd, J = 4.4,
13.6 Hz, 1H), 3.98 (q, J = 14.4 Hz, 2H), 4.30 (d,